HomeAI · summaries
Storia in 6 fonti
Supreme Court sides with Hikma in 'skinny label' case
The Supreme Court has unanimously sided with Hikma Pharmaceuticals and its “skinny label” version of a prescription-strength fish oil pill in a case that was closely watched by the generics industry.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
washingtonexaminer.com
Treatment for millions at stake in 'skinny label' Supreme Court case
The Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. ruling could have a major effect on incentives to invest in research for FDA‑approved medicines.
- ·
medpagetoday.com
Supreme Court Backs Maker of Generic Heart Drug in 'Skinny Label' Case
Court says defendant Amarin Pharma hasn't shown enough harm; remands case to lower court
